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Abstract 
Background: Human are confronted on a daily basis with contaminant pesticide residues in food, water and other 
components of the environment. Although the digestive system is the first organ to come into contact with food 
contaminants, very few data are available on the impact of low‑dose pesticide exposure during the in utero and post‑
natal periods on intestinal bacterial translocation (BT). Previous studies have revealed that chlorpyrifos (CPF) exposure 
is associated with intestinal dysbiosis and the contamination of sterile organs. Here, molecular typing was used to 
investigate intestinal bacterial translocation in rats exposed to chlorpyrifos in utero and during lactation. The translo‑
cated bacteria were profiled, and CPF tolerance and antibiotic resistance traits were determined.
Methods: A total of 72 intestinal segments and extra‑intestinal organs were obtained from 14 CPF‑exposed rats. The 
samples were cultured to isolate bacterial strains that had tolerated treatment with 1 or 5 mg CPF/kg bodyweight/
day in vivo. Strains were identified using matrix‑assisted laser desorption/ionization (MALDI) Biotyper. The disk diffu‑
sion method was used to determine the antibiotic susceptibility. The isolates were genotyped with PCR assays for the 
enterobacterial repetitive intergenic consensus sequence and random amplification polymorphic DNA.
Results: Bacterial translocation was confirmed for 7 of the 31 strains (22.6 %) isolated from extra‑intestinal sites. Over‑
all, the most prevalent bacteria were Staphylococcus aureus (55.5 % of the 72 intestinal and extra‑intestinal isolates), 
Enterococcus faecalis (27.7 %) and Bacillus cereus (9.8 %). 5 % of the S. aureus isolates displayed methicillin resistance. 
Seventy two strains were identified phenotypically, and seven translocated strains (mainly S. aureus) were identified by 
genotyping. Genotypically confirmed translocation was mainly observed found in pesticide‑exposed groups  
(6 out of 7).
Conclusion: BT from the intestinal tract colonized normally sterile extra‑intestinal organs in CPF‑exposed rats. Our 
findings validate the use of molecular typing for the assessment of intestinal BT in CPF‑exposed rats during critical 
periods of development.
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Background
Highly toxic organophosphorus compounds are the main 
constituents of many of the agricultural, industrial, and 
residential insecticides used worldwide. The acute toxic-
ity associated with high doses of organophosphorus pes-
ticides is caused by inhibition of acetylcholinesterase and 
the resulting increase in synaptic acetylcholine levels [1]. 
However, there is substantial evidence to show that this 
mechanism alone cannot account for the wide range of 
harmful effects associated with organophosphorus pesti-
cides—especially when the level of exposure is below the 
threshold for acute toxicity [2].
Chlorpyrifos (CPF) is a major organophosphorus 
insecticide. It is used to treat fruit and vegetable crops 
and exists as chlorpyrifos ethyl [the most toxic form: 
O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl)-phosphoro-
thionate; chemical formula: C9H11Cl3NO3PS] and chlor-
pyrifos methyl.
Although CPF residues can be found in cereals, fruit, 
vegetables and (potentially) meat and drinking water, few 
studies have focused on the compound’s putative impact 
on the digestive tract. Tirelli et  al. [3] have shown that 
CPF increases membrane permeability in an enterocyte 
cell culture model. Furthermore, Joly Condette et  al. 
[4] showed for the first time that low-dose chlorpyri-
fos exposure in  vivo causes morphological changes in 
the intestinal epithelium, alters intestinal permeability 
and increases bacterial translocation (BT, as detected 
by culture-based methods). In rats, this phenomenon is 
associated with (and probably caused by) failure of the 
intestine’s barrier function and an imbalance of in the 
intestinal microbiota [5].
The intestinal microbial community is a complex eco-
system that influences the host’s physiology in many 
ways. The bacterial count in the caecum and colon 
reaches values of 1012/g in the feces, whereas nearby por-
tal blood, mesenteric lymph nodes (MLNs) and organs 
(like kidney, liver, spleen) are usually sterile. This illus-
trates the efficacy of this intestinal barrier.
Berg has defined BT as the migration of microorgan-
isms and their toxins from the intestinal lumen to sterile 
organs such as the MLNs, blood, and abdominal organs 
[6]. BT can lead to a local inflammatory response and a 
potential increase in intestinal permeability, which in 
turn can lead to systemic infection and multiple organ 
failure [7]. Arnold and Brody were the first to confirm 
the harmfulness of BT in animals [6, 8]. In humans, some 
degree of BT is observed in Crohn’s disease, neutropenia, 
hemorrhagic shock, necrotizing enterocolitis, delayed 
sepsis, systemic inflammatory response syndrome, and 
multi-organ failure [9, 10]. Reduced blood flow in the 
gut, trauma, chronic inflammation, and immunosuppres-
sion are all factors that enhance BT [11].
BT from the intestine is most commonly detected by 
measuring the presence of viable bacteria in extra-intes-
tinal target tissues. This reflects not only the integrity of 
the mucosal barrier function but also the numbers and 
types of microbes in the lumen. Translocation may occur 
by three mechanisms: (i) through microfold cells [12] (a 
normal processing pathway that is especially active dur-
ing specific life periods, including the neonatal period) 
[13–15]; (ii) through intestinal epithelial cells (a major 
pathway after cellular injury such as that caused by cyto-
toxic drugs) [16], and (iii) after bacterial overgrowth and/
or impairment of host defenses [7].
Since the digestive system appears to be a target for 
CPF and the only study on BT in this context was based 
on conventional microbiological tests, we repeated our 
original study by using molecular techniques to inves-
tigate intestinal BT (to the liver, spleen, MLNs, Peyer’s 
patches, and kidney) in CPF-exposed rats, identify spe-
cific bacterial strains, and confirm the bacteria’s intestinal 
origin.
Lastly, we sought to determine whether prolonged, 
low-dose exposure to CPF for different periods of time 




All animal experiments were approved by the Animal 
Care and Use Committee at Jules Verne University of Pic-
ardy (Amiens, France: reference #2011/A/1).
The laboratory animals used in this study (15 female 
and 5 male Wistar Hannover rats; age on delivery: 
8  weeks; body weight range: 215–300  g) were obtained 
from Janvier Labs (Le Genest-Saint-Isle, France). The rats 
were allowed to acclimatize to the laboratory for at least 
one week period prior to the experiment. The animals 
were housed in plastic cages and fed a diet of standard rat 
pellets. Water was provided ad libitum. The protocol has 
been described previously [4].
Schedule for CPF treatment
After the acclimation period, female rats were mated 
with males (two females per male). Once a positive smear 
was observed, dams received daily doses of the respective 
treatment from days 0 to 21 (D21, the day of weaning) 
by oral gavage. Three exposure groups were studied: the 
rats in the CPF0 (control) group received 1 mL/kg body-
weight (BW) of rapeseed oil; the rats in the CPF1 group 
received 1 mg/kg BW/day of CPF in rapeseed oil, and the 
rats in the CPF5 group received 5 mg/kg BW/day of CPF 
in rapeseed oil. The rats in the litters were studied at two 
time points: firstly at weaning (after having been exposed 
to CPF in the dam’s milk (D21: CPF0, n = 7; CPF1, n = 8, 
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and CPF5, n = 6) and secondly in young adulthood (after 
the young rats had been gavaged with CPF individually 
from weaning to the age of 60 days (D60: CPF0, n =  5; 
CPF1, n = 7, and CPF5, n = 8).
Definition of BT
In an individual rat, BT was defined as the presence of the 
same bacterial species [with identical or closely related 
enterobacterial repetitive intergenic consensus (ERIC2) 
sequence and random amplification polymorphic DNA 
(RAPD) patterns in PCR assays] in both the intestinal 
segments and the normally sterile extra-intestinal organs.
Tissue cultures
The tissue specimens obtained from each rat were sepa-
rately mashed, dilacerated, and homogenized in 9  mL 
of Ringer’s solution in a sterile lab blender bag (Stom-
acher®, Seward Medical Ltd, Worthing, UK). Next, 1 mL 
of the homogenate was diluted to one tenth of its origi-
nal concentration (1:10). 100 μL volume of each diluted 
homogenate was inoculated onto aerobic and anaerobic 
Columbia blood agar, chocolate agar, and Chapman agar 
plates (bioMérieux, Marcy l’Etoile, France), which were 
incubated at 35 ± 2 °C in 5 % CO2 for 24–72 h. Isolates 
grown from samples (i.e. each colony) were numbered 
and identified on the basis of their characteristic colonial 
and microscopic appearances and matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry 
(MALDI–TOF-MS) pattern.
Definition of duplicates
Rats that produced more than one positive sample for the 
same bacterium with the same phenotypic expression of 
antibiotic susceptibility were assessed only once. Hence, 
duplicates were excluded from the study.
Bacterial identification by MALDI Biotyper
A MALDI–TOF-MS system (Autoflex III, Bruker Dalton-
ics, Billerica, MA, USA) was used to examine each unique 
colony of microorganisms isolated by culture, according 
to a previously described procedure [17–19]. In brief, 
samples were prepared with absolute ethanol, and 1  μL 
of matrix solution (2,5-dihydroxybenzoic acid 50 mg/mL, 
30  % acetonitrile, 0.1  % trifluoroacetic acid) was added. 
The analytical data were processed with Bruker Biotyper 
software (version 2.0, Bruker Daltonics), as described 
previously [20]. Identifications were performed in dupli-
cate, according to the manufacturer’s instructions.
Antibiotic susceptibility testing
As recommended by the Comité de l’Antibiogramme de la 
Société Française de Microbiologie [21], the disk diffusion 
method (with Mueller–Hinton agar at 35 ± 2 °C for 24 h) 
was used to test the bacterial isolates’ antibiotic suscepti-
bility. Staphylococcus aureus and Staphylococcus warneri 
were tested for susceptibility to the following 20 anti-
biotics: streptomycin (10  µg), kanamycin (30  μg), gen-
tamicin (30 μg), tobramycin (30 μg), fosfomycin (50 μg), 
doxycycline (30  μg), trimethoprim–sulfamethoxazole 
(1.25 +  23.75 μg), erythromycin (Er: 15 μg), lincomycin 
(L: 15  μg), pristinamycin (PT: 15  μg), rifampin (30  μg), 
ofloxacin (OFX: 5  μg), vancomycin (30  μg), teicoplanin 
(30 μg), linezolid (10 μg), fusidic acid (10 μg), benzylpeni-
cillin (PEN: 6 μg), oxacillin (OXA: 5 μg), cefoxitin (FOX: 
30 μg), and moxalactam (30 μg). Enterococcus faecalis was 
tested for susceptibility to ampicillin (10 μg), kanamycin 
(1000  μg), gentamicin (500  μg), streptomycin (500  μg), 
Er (15  μg), L (15  μg), PT (15  μg), teicoplanin (30  μg), 
vancomycin (30  μg), trimethoprim–sulfamethoxazole 
(1.25 + 23.75 μg), and linezolid (10 μg). The isolates were 
classified as susceptible (S), intermediate (I) and resistant 
(R) on the basis of established breakpoint values [21].
Determination of the bacterial strains’ clonality
Total nucleic acids were extracted from bacteria grown 
on Columbia agar supplemented with 5  % sheep blood 
incubated at 35  ±  2  °C for 18–24  h. Each a bacte-
rial colony was suspended in 300  μL of distilled water, 
transferred to 1.5 μL microfuge tubes, and incubated at 
95 °C for 10 min. The cell suspension was incubated in a 
bath-type ultrasonic sonicator (Gen-Probe; bioMérieux, 
Craponne, France) for 15  min and then centrifuged at 
13,500  rpm for 10  min. A 400  μL aliquot of eluate was 
carefully transferred to a new sterile Eppendorf tube and 
stored at −20 °C until use in the polymerase chain reac-
tion (PCR) assays. PCR was performed in a final volume 
of 50 μL of the corresponding ready-to-use Master Mix 
buffer from the TopTaq Master Mix Kit (Qiagen, Venlo, 
Netherlands). Each reaction mixture contained 25 μL of 
Master Mix buffer, 20  μM of ERIC2 primer (5′-AAG-T 
AA-GTG-ACT-GGG-GTG-AGC-G-3′) [22] or 20  μM 
of RAPD1 PRIMER (5′-GCT-TGG-GTG-AGA-ATT-GC 
A-GG-3′) [23], with 1.5 μL of DNA for ERIC2 and 2 μL of 
DNA for RAPD) used as a template, and 5 μL of colored 
loading buffer for each PCR.
The amplification conditions for ERIC2-PCR were as 
follows: 7 min at 94 °C, followed by 45 cycles of 1 min at 
94  °C, 1  min at 45  °C, and 2  min at 72  °C, with a final 
extension of 7  min at 72  °C. The conditions for RAPD-
PCR were as follows: 3 min at 94 °C, followed by 45 cycles 
of 1 min at 94 °C, 1 min at 36 °C, and 5 min at 72 °C, with 
a final extension of 7 min at 72 °C. All PCRs were carried 
out in a GeneAmp 2400 thermal cycler (Perkin Elmer 
Inc., Waltham, MA, USA).
PCR products were resolved by electrophoresis on a 
1  % agarose gel in Tris–acetate-EDTA (Sigma-Aldrich, 
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USA) containing 0.5 μg/mL of ethidium bromide. Smart-
Ladders® (200–10  kb; Eurogentec, Seraing, Belgium) 
were used as molecular weight markers. The gel profiles 
were photographed with an ultraviolet light transillumi-
nator (ChemiDoc Touch Imaging System, Bio-Rad Lab-
oratories, Marnes-la-Coquette, France) and processed 
with Image Lab software (version 5.2.1, Bio-Rad).
Statistical analysis
All statistical analyses were performed with R software 
(version 3.1.0; Lucent Technologies, Murray Hill, NJ, 
USA).
The frequency of BT was quoted with its 95  % con-
fidence interval (CI, calculated using the “minlike” 
method) [17]. A mixed logistic regression model was 
used to determine the relationships between the likeli-
hood of BT on one hand and exposure and age on the 
other. The odds ratio (OR) [95 % CI] for BT was also cal-




Out of a total of 126 cultured tissue samples, 46 were 
negative and 80 were positive. After eliminating dupli-
cates (see below), 72 positive samples (40 intestinal frag-
ments and 32 samples from extra-intestinal organs) were 
studied.
When considering the 72 samples from various sites 
(Table  1), S. aureus was the most commonly identified 
organism (n  =  40 positive samples, 55.5  %), followed 
by E. faecalis at (n = 20, 27.7 %), Bacillus cereus (n = 7, 
9.8 %), S. warneri (n = 3, 4.2 %) and Micrococcus luteus 
(n = 2, 2.8 %).
Antibiotic susceptibility
The susceptibility results showed that 38 of the 40 S. 
aureus isolates (95 %) were methicillin-susceptible, and 2 
(5 %) were resistance to methicillin and OFX (i.e. methi-
cillin-resistant S. aureus, MRSA).
All S. warneri, B. cereus and M. luteus isolates were 
susceptible to the antibiotics tested with the Staphylococ-
cus genus, except for two strains of S. warneri that were 
resistant to fusidic acid and Er.
For E. faecalis, all isolates were susceptible to ampi-
cillin, vancomycin, teicoplanin and trimethoprim–sul-
famethoxazole, and all were resistant to L. The E. faecalis 
isolates showed a low-to-moderate level of resistance to 
Er [11 out of 20 were susceptible (55 %) and 9 (45 %) were 
resistant] and PT [14 were susceptible (70 %) and 6 were 
resistant (30 %)].
Genotyping
We isolated 72 strains of S. aureus, E. faecalis and B. 
cereus from samples collected from 14 rats. The strains 
were compared with each other by using ERIC2-PCR and 
Table 1 Distribution of bacterial strains by sample type (n = 72)
Samples
Strains Intestinal segments No Extra-intestinal organs No Total




















Subtotal 28 12 40














Subtotal 10 10 20
Bacillus cereus (n = 7) Ileum 2 Kidney 5
Subtotal 2 5 7




Subtotal 0 3 3




Subtotal 0 2 2
Total 40 32 72
Page 5 of 12Joly Condette et al. Gut Pathog  (2016) 8:50 
RAPD-PCR assays. The other species (S. warneri and M. 
luteus) found in samples from three rats (animal ID num-
bers: 19.9, 15.8 and 3.8) were not typed because of their 
lower prevalence.
The S. aureus isolates were compared in an ERIC2-PCR 
analysis (n = 40). A total of 28 distinct ERIC2-PCR types 
were detected (referred to as E1 through E28). ERIC2-
PCR types E21, E22, and E25 included four isolates each 
(isolates 24, 25, 38 and 40 for E21; isolates 26, 27, 34, and 
35 for E22, and isolates 30–33 for E25). Within each pro-
file, the isolate were genetically related. Two isolates each 
were found for E9 (isolates 9 and 10), E15 (isolates 16 and 
17), and E16 (isolates 18 and 20).
The remaining profiles included one isolate each. In 
an RAPD-PCR analysis, the 40 S. aureus isolates were 
differentiated into 12 distinct types (referred to as R1 
through R12). The nucleic acids of two isolates (1 and 
2) could not be studied because the strain was not suffi-
ciently viable. The following RAPD types had genetically 
identical isolates within each profile: R2 consisted of 
seven identical isolates (isolates 4, 17, 19, 21, 23, 25 and 
27), R3 consisted of six identical isolates (5–7 and 9–11), 
R8 consisted of five identical isolates (18, 20, 22, 24, and 
26), R11 consisted of four identical isolates (30–33), R12 
consisted of three identical isolates (34–36), R10 con-
sisted of three identical isolates (37–39), R6 consisted 
of two identical isolates (13 and 14), and R7 consisted of 
two identical isolates (15 and 16) (Fig. 1a, b).
ERIC2- and RAPD-PCRs were then used to evaluate 
the relatedness of B. cereus isolates (n  =  7). Four pat-
terns were generated with the ERIC primer (denoted by 
E1 through E4): E4 included four isolates (48–50), E1 
included two isolates (44 and 45), and one isolate each 
was found for patterns E2 (isolates 46) and E3 (isolates 
47). RAPD-PCR revealed three profiles (designated as R1 
through R3): four genetically indistinguishable isolates 
were found for the profiles R1 (44–46) and R3 (48–50). 
The R2 pattern was considered to be an unrelated type 
(isolate 47) (Fig. 2a, b).
ERIC2-PCRs of E. faecalis isolates (n = 20) revealed ten 
patterns (denoted by E1 through E10). Pattern E6 com-
prised five isolates (58–61 and 63), pattern E9 comprised 
four isolates (65, 66, 71, and 72), pattern E10 comprised 
three isolates (67–69), and pattern E2 comprised two iso-
lates (64 and 70). Within each profile, all the isolates were 
genetically identical. The remaining patterns (E1, E5 and 
E7) consisted of one isolate each.
RAPD-PCRs of E. faecalis generated 13 distinct profiles 
(denoted by R1 through R13). Three isolates each were 
found for the patterns R5 (58, 59 and 60) and R11 (67, 
68 and 69). Patterns R2 (isolates 54 and 62), R3 (isolates 
55 and 56), and R13 (isolates 71 and 73) comprised two 
isolates each. Within each profile, all the isolates were 
genetically identical. The remaining profiles included one 
genetically unrelated isolate each (Fig. 3a, b).
Assessment of genetic groups
The combination of S. aureus isolates obtained with 
ERIC2-PCR and RAPD-PCR enabled us to define 34 
genetic groups (Ggs, denoted by A through Z and AA 
through JJ). Gg DD (patterns E25-R11) included four iso-
lates (30–33), whereas two isolates each were found for 
GgI (9 and 10 for patterns E9-R3), GgQ (18 and 20 for 
patterns E16-R8), and Gg EE (38 and 40 for patterns E21-
R12). Within each Gg, all the isolates were genetically 
identical. The other Ggs comprised one isolate each and 
were considered to be unrelated.
The combined typing results for B. cereus strains 
revealed four Ggs (denoted by A through D). GgA 
included two isolates (44 and 45) and GgD consisted of 
three isolates (48–50). Within each group, these isolates 
were genetically similar to each other. One isolate each 
was determined for GgB (46) and GgC (47); these isolates 
were considered to be unrelated.
Combining the ERIC2-PCR and RAPD-PCR patterns 
for E. faecalis gave 16 Ggs (referred to as I through XVI). 
The strains in each group (isolates 58–60, Gg VI), (iso-
lates 67–69, Gg XIII), and (isolates 71 and 72, Gg XVI) 
were genetically related. The remaining groups included 
one isolate each and showed polyclonal heterogeneity.
Bacterial translocation
Translocation was observed in 7 of the 31 CPF-exposed 
strains (22.6 %, with a 95 % CI of [7–36 %]; Table 2). Five 
were detected at D21 and 2 were detected at D60; one 
belonged to the CPF0 group, 3 (42.9 %) belonged to the 
CPF1 group and the remaining 3 (42.9 %) belonged to the 
CPF5 group (Fig. 4a, b).
Of the 24 BT-free rats, 8 (33.4 %) belonged to the CPF0 
group, 10 (41.6  %) belonged to the CPF1 group, and 
6 (25  %) belonged to the CPF5 group; 16 (66.6  %) were 
detected at D21 and 8 (33.4  %) were detected at D60 
(Table 3). Translocation increase with CPF exposure (OR 
[95 % CI] = 1.25 [0.22–7.15]), although this was not sta-
tistically significant (p =  0.7981). Furthermore, translo-
cation was more likely on D21 than on D60 (OR [95  % 
CI] =  1.25 [0.22–7.15]); again, the OR was not statisti-
cally significant (p = 0.7981).
The bacteria that had translocated from the intestinal 
tract and were detected in the extra-intestinal samples 
were distributed as follows: 5 of the 40 S. aureus isolates 
(12.5  %) from the caecum (n =  4) or the colon (n =  1) 
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had translocated to the kidneys (n  =  3), adipose tissue 
(n = 1) or Peyer’s patches (n = 1). One of the 20 E. fae-
calis isolates (5 %) from the caecum had translocated to 
the liver, and one of the 7 B. cereus isolates (14.2 %) from 
the ileum had translocated to the kidneys (Table 2). The 
typing assay results confirmed these data. By combining 
the ERIC2-PCR and RAPD-PCR patterns, we found that 
14 isolates were included in six genetic groups: GgII (iso-
lates 9 and 10), GgQ (isolates 18 and 20), GgDD (isolates 
30–33), and GgEE (isolates 38 and 40) for S. aureus; GgD 
(isolates 48 and 49) for B. cereus; and GgVI (isolates 58 
and 59) for E. faecalis—indicating that (i) these isolates 
were involved in the translocation process and (ii) the 
isolates within each Gg were clonally related.
Discussion
Although molecular typing has often been used to char-
acterized BT in a clinical setting [24, 25], there are few 
literature data on the use of these techniques to detect 
translocation from the intestinal tract in animal models 
[26]. To the best of our knowledge, the present study is 
the first to have employed molecular typing (ERIC2-PCR 
and RAPD-PCR) techniques in the detection of BT in the 
rat. We observed BT during critical life periods in 22.5 % 
of the studied CPF-exposed rats. In studies of rats with 
ascites and carbon-tetrachloride-induced cirrhosis, the 
prevalence of BT ranged from 36.8 to 97.6 % [27–30]. In 
a clinical study, positive MLN cultures were found for 
32.1 % of patients with cirrhosis [31].
Fig. 1 a ERIC‑PCR profiles for S. aureus: Lines 1–40 isolate numbers (above gels) and pattern types (below gels). Molecular weights (MW) are 
expressed in SmartLadder base pairs (bp). The 40 isolates were differentiated into 28 distinct ERIC‑PCR patterns (E1–E28). b RAPD‑PCR profiles for  
S. aureus: Lines 3–40 isolate numbers (above gels), and pattern types (below gels). Molecular weights (MW) are expressed in SmartLadder base pairs 
(bp). The 38 isolates were differentiated into 12 distinct types (R1–R12)
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These findings indicate that the prevalence of BT 
depends on the type of study and the detection meth-
ods used (bacteriological culture of MLN samples). It 
has been reported that bacterial DNA in the biological 
fluids is a marker for BT in rats with cirrhosis [28, 31]; 
this suggests that the definition of BT has been widened 
to the passage of bacterial fragments (endotoxins, bacte-
rial DNA, etc.) from the intestinal lumen to the MLNs 
and into the circulatory system in general. Although 
they came from the same species, translocated strains 
and non-translocated strains differed clearly in terms 
of the ERIC2-PCR and RAPD-PCR patterns (77.5  % of 
strains). As reported in the literature [26], we concluded 
that BT did not occur in samples when the extra-intesti-
nal organs (liver, spleen, Peyer’s patches, MLNs, adipose 
tissue, and kidneys) were sterile. One could argue that 
the intestinal bacteria found in the extra-intestinal tis-
sue samples resulted from bacterial contamination and 
not from BT. Table 3 shows that 41.5 % (22 out of 53) of 
the isolates in the extra-intestinal tissues were not found 
in intestinal tissues. Conversely, 58.5 % (31 out of 53) of 
the isolates in intestinal tissues were absent from extra-
intestinal samples. This discrepancy might have been 
due to slight differences between the intestinal bacterial 
counts in rats with BT vs. rats without BT. Our results 
contradicts the literature data on BT in animal models, 
Fig. 2 a ERIC‑PCR profiles for B. cereus: Lines 44–50 isolate numbers 
(above gels) and pattern types (below gels). The seven isolates were 
differentiated into four distinct types (E1–E7). b RAPD‑PCR profiles for 
B. cereus: Lines 44–50 isolate numbers (below gels). The seven isolates 
were differentiated into three distinct types (R1–R3)
Fig. 3 a ERIC‑PCR profiles for E. faecalis: Lines 53–72 isolate numbers (above gels) and pattern types (below gels). Molecular weights (MW) are 
expressed in SmartLadder base pairs (bp). The 20 isolates were differentiated into ten distinct types (E1–E10). b RAPD‑PCR profiles for E. faecalis: 
Lines 53–72 isolate numbers (above gels) and pattern types (below gels). Molecular weights (MW) are expressed in SmartLadder base pairs. (bp). The 
20 isolates were differentiated into 13 distinct type (R1–R13)
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in which bacterial overgrowth was identified as a major 
BT-promoting factor [32]. In rats, anaerobic bacteria pre-
dominate in the ileum, caecum and colon. This anaerobic 
flora rarely translocates, and thus limits the colonization 
and growth of potentially translocating bacteria. The 
intestinal mucosa thus constitutes a barrier against BT 
via the transcellular route (through enterocytes) or the 
paracellular route (at tight junctions). Studies in animals 
have shown that some antibiotics (such as norfloxacin 
and trimethoprim–sulfamethoxazole) selectively reduce 
intestinal bacterial overgrowth (and thus BT) by chang-
ing the composition of the bacterial flora. In a cirrhotic 
rat model, the administration of propranolol or cisapride 
stimulated intestinal motility by speeding up intestinal 
transit, decreasing bacterial overgrowth, improving intes-
tinal permeability and reducing BT. Similarly, the admin-
istration of conjugated biliary acids (cholylsarcosine and 
cholylglycine) suppressed intestinal bacterial overgrowth 
and reduced BT. Lastly, the use of antioxidants alone or 
in combination with probiotics (Lactobacillus) in cir-
rhotic rats reduced the intestinal bacterial load, BT, and 
oxidative stress in the intestinal wall.
Several previous studies have investigated the effect of 
CPF on the intestinal wall (ileum and colon) [4, 5]. Expo-
sure to CPF decreases the mRNA expression of genes 
encoding the tight junction proteins (including claudin-4 
and zonula-1); this increases intestinal permeability, ena-
bles BT and activates the immune system. In the present 
study, all the bacterial strains isolated from individual 
samples from CPF-exposed rats were found to be viable 
on agar plates, which suggests that the strains tolerated 
CPF doses of 1 mg/kg BW and 5 mg/kg BW in vivo. All 
of the isolates were then tested for their susceptibility to 
Table 2 Isolates for which bacterial translocation was confirmed (7 out of 31 isolates)
Prevalence: 22 % (7 out of 31)
Translocation of S. aureus was evidenced in 5 of the 40 caecum and colon samples (12.5 %); translocation to the kidney: n = 3; translocation to adipose tissues: n = 1; 
translocation to Peyer’s patches: n = 1
Translocation of B. cereus was evidenced in 1 of 7 ileum samples (14.2 %); translocation to adipose tissues
Translocation of E. faecalis was evidenced in 1 of 20 caecum samples (5 %); translocation to the liver
Bacterial strains Rat ID number Age (days) CPF group Isolates No Intestinal segments Extra-intestinal organs
Staphylococcus aureus (n = 10) 12.6 D21 CPF0 9 Caecum –
10 – Adipose tissues
18.6 D21 CPF1 18 Colon –
20 – Kidney
6.14 D60 CPF1 30 Caecum –
31 – Peyer’s patch
4.4 D21 CPF5 Caecum –
– Kidney
4.7 D60 CPF5 38 Caecum –
40 – Kidney
Bacillus cereus (n = 2) 13.2 D21 CPF5 48 Ileum –
49 – Kidney
Enterococcus faecalis (n = 2) 15.8 D21 CPF1 58 Caecum –
59 – Liver
Fig. 4 Translocated isolates. a ERIC‑PCR profiles for S. aureus [lines (9, 
10), (18, 20), (30, 31), (32, 33), (38, 40)]; B. cereus (lines 48, 49), and  
E. faecalis (lines 58, 59): isolate numbers (above gels) and pattern types 
(below gels). Molecular weights (MW) are expressed in base pairs (pb). 
b RAPD‑PCR profiles for S. aureus [lines (9, 10), (18, 20), (30, 31), (32, 
33), (38, 40)]; B. cereus (48, 49); and E. faecalis (58, 59): isolate numbers 
(above gels) and pattern types (below gels). Seven isolates (as defined 
genotypically) were found to have translocated
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Table 3 Isolates for which bacterial translocation was not confirmed (24 out of 31 isolates)
Bacterial strains Rat ID number Age (days) CPF group Isolates No Intestinal segments Extra-intestinal organs
Staphylococcus aureus (n = 30) 1 Ileum –
14.7 D21 CPF0 2 Caecum –
3 – Liver
19.9 D21 CPF0 4 Caecum –
5 – Liver
6 Ileum –
12.6 D21 CPF0 7 Ileum –
8 Colon –
19.4 D60 CPF0 11 Colon –
12 Caecum –
13 Ileum –
19.5 D60 CPF0 14 Colon –
15 Caecum –
16 – Peyer’s patch
18.6 D21 CPF1 17 Ileum –
19 – Spleen
21 Colon –
15.8 D21 CPF1 22 Caecum –
23 – Liver
24 Caecum –
24.7 D21 CPF1 25 – Kidney
26 – Spleen
27 Colon –
8.13 D60 CPF1 28 Caecum –
29 – Kidney
34 Ileum –
13.2 D21 CPF5 35 Colon –
36 Caecum –
4.7 D60 CPF5 37 Colon –
39 – Mesenteric lymph node
Enterococcus faecalis (n = 18) 12.6 D21 CPF0 53 Colon –
19.14 D60 CPF0 54 – Liver
55 Colon –
18.6 D21 CPF1 56 Colon –
15.8 D21 CPF1 57 Colon –




6.14 D60 CPF1 64 – Peyer’s patch
65 – Peyer’s patch
66 – Peyer’s patch
3.8 D21 CPF5 67 Colon –
4.4 D21 CPF5 68 – Kidney
69 – Kidney
4.7 D60 CPF5 70 Colon –
71 – Mesenteric lymph node
72 – Kidney
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20 antibiotics. Over 90 % of the detected bacterial strains 
were susceptible; 2 strains (5  %) of S. aureus expressed 
the MRSA phenotype (PENr OXAr FOXr) but were sus-
ceptible to the remaining antibiotics, 9 isolates (45  %) 
of E. faecalis were resistant to Er, 6 isolates (30 %) were 
resistant to PT, and 100 % of the isolates were resistant 
to L (natural resistance). For E. faecalis, 3 isolates (15 %) 
expressed the macrolide-lincosamide-streptogramin B 
(MLSB)  +  streptogramin A (SA) phenotype (ErrLrPTr), 
and 12 isolates (60  %) expressed the MLSB phenotype 
(ErrLrPTs). In strains expressing the MLSB phenotype, 
the genes encoding resistance are located on a 20–30 kb 
plasmid [33]. However, resistance is chromosome-
encoded in the majority of strains isolated in France 
[33]. Resistance to macrolide, lincosamide, SA (PT) and 
SB (virginiamycin) is associated with the production of 
an SA-inactivating mutant acetyltransferase and an SB-
inactivating mutant hydrolase [34–36]. Expression of the 
MRSA phenotype and susceptibility to other antibiotics 
has been documented in the literature [17, 37–40].
Methicillin resistance is associated with a specific 
mechanism in which a mobile genetic element [the 
staphylococcal cassette chromosome (SCC) mec] inte-
grates into the S. aureus chromosome. In the S. aureus 
chromosome, the mec A gene encodes a specific, methi-
cillin-resistant transpeptidase (penicillin-binding pro-
tein 2a) [38], which results in resistance to all β-lactam 
antibiotics (due to a low affinity for binding to β-lactam). 
The classic mecA gene codes for resistance to methicil-
lin, kanamycin, gentamicin (in most cases), tobramycin, 
amikacin, Er, and L but not for resistance to PT and OFX. 
A new mecA homolog mecB strain (N315) [37, 38] and a 
mecC strain (LGA256) [39, 40] have been identified. The 
SCC elements classified as mecB or mecC share ≥70  % 
nucleotide sequence identity with the classic mecA gene. 
In the present study, the isolates were phenotypically 
resistant to all β-lactams but remained susceptible to 
other tested antibiotics and thus corresponded chromo-
somally to the mecC gene. Our results are in agreement 
with the literature data [17, 37–40]. When considering 
the genotyped strains, resistant strains (B. cereus and E. 
faecalis) were only found in the CPF groups (both CPF1 
and CPF5)—particularly in juvenile rats at D21. Naphade 
et al. [41] detected 9.8 and 26.2 kDa plasmids in bacterial 
cultures from garden soil, indicating that the ability to 
tolerate high concentrations of heavy metal salts, pesti-
cides and antibiotics is a plasmid-encoded characteristic. 
Harishankar et al. [42] study of five model intestinal bac-
teria found that Lactobacillus fermentum, Lactobacillus 
lactis, and Escherichia coli tolerated high concentrations 
of CPF (>1400 µg/mL), whereas E. faecalis and Lactoba-
cillus plantarum tolerated lower concentrations (400 and 
100 μg/mL, respectively).
The three most tolerant bacteria (L. fermentum, L. lac-
tis, and E. coli) produced an organophosphorus phos-
phatase that degrades CPF; the concentration of CPF 
was higher outside the cells (i.e. in the supernatant) than 
inside the cells. L. fermentum degraded 70 % of the CPF 
(with 3,5,6-trichloro-2-pyridinol as the end product), L. 
lactis degraded up to 61  % of the CPF (with CPF oxon 
as the end product), whereas E. coli degraded only 16 % 
of the CPF (with CPF oxon and diethylphosphate as the 
end products). This microbial variation in pesticide tol-
erance was dependent on the end-product degradation 
profiles and/or the types of end products [43, 44]. Shafiani 
and Malik [44] reported that a Pseudomonas spp. isolated 
from soil was able to tolerate up to 800 μg/mL of endosul-
fan, 1600 μg/mL of carbofuran and 1600 μg/mL of mala-
thion. All of the bacterial isolates were further tested for 
their antibiotic susceptibility to seven different antibiot-
ics. A bacteriological analysis of endosulfan-exposed soil 
by Sepperumal et al. [45] revealed the presence of Bacil-
lus ciradans, Pseudomonas spp., Bacillus lentus, Acine-
tobacter spp., and B. cereus. Additional plasmid-curing 
experiments were performed to determine whether pes-
ticide resistance traits in these bacteria were encoded on 
a plasmid or on the bacterial chromosome. Furthermore, 
B. ciradans and Acinetobacter spp. contained plasmids of 
7 and 4 kb in size, respectively. Once BT has occurred, the 
isolation of viable bacteria in the liver, spleen, adipose tis-
sue, MLNs and kidneys depends on (i) the immunological 
competence of the host and (ii) individual bacterial viru-
lence factors that prevent the pathogen’s destruction [46].
We were unable to isolate anaerobic bacteria from the 
Enterobacteriaceae family; this constitutes a study limita-
tion. In holoxenic rats, the stomach and bowel is mainly 
Table 3 continued
Bacterial strains Rat ID number Age (days) CPF group Isolates No Intestinal segments Extra-intestinal organs
Bacillus cereus (n = 5) 19.9 D21 CPF 0 44 Ileum –
15.8 D21 CPF1 45 – Kidney
46 – Kidney
8.13 D60 CPF1 47 – Kidney
13.2 D21 CPF5 50 – Kidney
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colonized from birth to weaning by Lactobacillus, Strep-
tococcus and Enterococcus genera, where as Enterobacte-
riaceae and anaerobic bacteria are absent [47, 48]. After 
weaning, the pups’ bacterial flora downstream of the 
ileum and caecum predominantly consists of anaerobic 
bacteria [49]. These results are consistent with Raybaud 
et al. [44] observation of the absence of the Enterobacte-
riaceae family. However, our failure to isolate anaerobic 
bacteria was probably due to the detection technique 
used.
In conclusion, our earlier morphological and molecu-
lar analyses showed that long-lasting exposure to CPF 
(an organophosphate insecticide observed as food resi-
dues) altered the maturation of the rat intestine and was 
associated with intestinal dysbiosis and BT towards ster-
ile organs [4, 5]. In the present study, we confirmed the 
occurrence of BT and validated the use of molecular typ-
ing in rats exposed to CPF in utero and during lactation.
The present study showed that molecular typing can 
detect intestinal BT in CPF-exposed rats; a combination 
of ERIC2-PCR and RAPD-PCR patterns can be used as 
a DNA fingerprint for intestinal microfloral strains. The 
most prevalent bacteria in intestinal samples from CPF-
exposed rats were S. aureus, E. faecalis and B. cereus. 
Furthermore, chromosome- and plasmid-encoded pes-
ticide-tolerance and antibiotic-resistance traits were 
observed in S. aureus and E. faecalis strains.
Lastly, we believe that our present findings provide 
strong evidence to show that early in utero and lacta-
tional exposure to CPF may have short- and long-last-
ing impacts on the digestive system. Importantly, CPF 
is found in cereals, fruit, vegetables and (potentially) in 
meat and drinking water, and is known to cross the pla-
cental barrier. Under normal circumstances, the intesti-
nal epithelium acts as a barrier against food antigens and 
commensal bacteria. The latter bacteria live in symbio-
sis with the host and are significantly involved in physi-
ological functions. The present data on gut homeostasis 
indicate that CPF disrupts the gut maturation, alters the 
bacterial equilibrium and enhances BT towards ster-
ile organs. Moreover, the observed effect may be even 
greater during the food diversification period that occurs 
after weaning. Hence, we strongly believe that pesticide 
exposure in infancy (when the digestive system is still 
immature) should be avoided as much as possible.
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